CN Patent

CN110087655A — 9-氨基甲基米诺环素化合物及其在治疗社区获得性细菌性肺炎(cabp)中的用途

Assigned to Paratek Spv2 Co ltd · Expires 2019-08-02 · 7y expired

What this patent protects

本文公开的本发明提供在口服或IV剂量或两者的组合中使用9‑[(2,2‑二甲基‑丙基氨基)‑甲基]‑米诺环素或其盐治疗社区获得性细菌性肺炎(CABP)的方法。

USPTO Abstract

本文公开的本发明提供在口服或IV剂量或两者的组合中使用9‑[(2,2‑二甲基‑丙基氨基)‑甲基]‑米诺环素或其盐治疗社区获得性细菌性肺炎(CABP)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110087655A
Jurisdiction
CN
Classification
—
Expires
2019-08-02
Drug substance claim
No
Drug product claim
No
Assignee
Paratek Spv2 Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.